HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

William H Frishman Selected Research

Adrenergic beta-Antagonists (beta-Adrenergic Blocking Agents)

1/2020Beta Adrenergic Blocker Use in Patients With Chronic Obstructive Pulmonary Disease and Concurrent Chronic Heart Failure With a Low Ejection Fraction.
9/2019The Preventive Role of Angiotensin Converting Enzyme Inhibitors/Angiotensin-II Receptor Blockers and β-Adrenergic Blockers in Anthracycline- and Trastuzumab-Induced Cardiotoxicity.
12/2007Diagnosis and management of viral myocarditis.
5/2002Innovative drug treatments for viral and autoimmune myocarditis.
1/2002Beta-adrenergic blockers in systemic hypertension: pharmacokinetic considerations related to the current guidelines.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


William H Frishman Research Topics

Disease

56Cardiovascular Diseases (Cardiovascular Disease)
09/2022 - 09/2002
55Heart Failure
06/2022 - 03/2002
44Hypertension (High Blood Pressure)
01/2022 - 01/2002
20Coronary Artery Disease (Coronary Atherosclerosis)
10/2021 - 07/2002
18Myocardial Infarction
10/2021 - 05/2003
15Atherosclerosis
09/2022 - 05/2004
14Stroke (Strokes)
07/2022 - 11/2002
13Myocardial Ischemia (Ischemic Heart Diseases)
07/2022 - 05/2003
10Inflammation (Inflammations)
09/2022 - 03/2005
10Diabetes Mellitus
11/2021 - 11/2002
9Obesity
06/2022 - 09/2006
8Coronary Disease (Coronary Heart Disease)
04/2018 - 09/2002
7Hyperlipidemias (Hyperlipidemia)
07/2022 - 09/2005
7Infections
03/2022 - 07/2002
7Cardiac Arrhythmias (Arrythmia)
09/2021 - 07/2003
7Hemorrhage
09/2021 - 11/2008
7ST Elevation Myocardial Infarction
11/2017 - 10/2013
6Dyslipidemias (Dyslipidemia)
06/2022 - 09/2004
6Neoplasms (Cancer)
10/2021 - 07/2016
6Chronic Renal Insufficiency
10/2021 - 06/2015
6Acute Coronary Syndrome
09/2021 - 11/2008
6Atrial Fibrillation
01/2020 - 05/2003
5Endocarditis
05/2022 - 09/2003
5Thrombosis (Thrombus)
03/2022 - 11/2008
5Chronic Kidney Failure (Chronic Renal Failure)
10/2021 - 03/2005
5Cardiomyopathies (Cardiomyopathy)
09/2021 - 05/2003
5Cardiotoxicity
09/2019 - 03/2017
5Heart Diseases (Heart Disease)
09/2016 - 09/2002
4Atherosclerotic Plaque (Atheroma)
03/2022 - 05/2004
4Cognitive Dysfunction
11/2021 - 07/2003
4Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left)
05/2014 - 03/2003
4Hypercholesterolemia
05/2010 - 10/2002
3COVID-19
05/2022 - 05/2021
3Rupture
03/2022 - 11/2008
3Dementia (Dementias)
11/2021 - 01/2002
3Cerebrovascular Disorders (Cerebrovascular Occlusion)
11/2021 - 05/2003
3Ventricular Tachycardia
09/2021 - 11/2014
3Amyloidosis
09/2021 - 01/2010
3Type 2 Diabetes Mellitus (MODY)
09/2020 - 05/2020
3Transient Ischemic Attack
07/2020 - 03/2004
3Vascular Diseases (Vascular Disease)
07/2020 - 09/2002
3Thromboembolism
07/2020 - 11/2013
3Myocarditis (Carditis)
03/2019 - 05/2002
3Heart Arrest (Cardiac Arrest)
07/2018 - 07/2014
3Cardiogenic Shock
11/2017 - 12/2013
3Hypotension (Low Blood Pressure)
07/2016 - 09/2006
3Alzheimer Disease (Alzheimer's Disease)
11/2013 - 01/2002
3Angina Pectoris
11/2011 - 01/2005
3Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy)
05/2003 - 01/2002
3Migraine Disorders (Migraine)
05/2003 - 07/2002

Drug/Important Bio-Agent (IBA)

26Pharmaceutical PreparationsIBA
03/2022 - 05/2002
19Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
09/2022 - 05/2003
12CholesterolIBA
09/2022 - 10/2002
12Antihypertensive Agents (Antihypertensives)IBA
05/2022 - 01/2002
10Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
09/2019 - 05/2002
9LipidsIBA
07/2022 - 09/2005
9DiureticsIBA
01/2022 - 05/2002
7oxidized low density lipoproteinIBA
09/2022 - 09/2005
7Angiotensin Receptor AntagonistsIBA
09/2019 - 05/2002
7EnzymesIBA
11/2018 - 05/2004
6LDL CholesterolIBA
09/2022 - 03/2009
6CytokinesIBA
03/2022 - 01/2009
5LDL Lipoproteins (beta Lipoproteins)IBA
09/2022 - 09/2005
5Hypoglycemic Agents (Hypoglycemics)IBA
05/2022 - 01/2003
5Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA
03/2022 - 05/2003
5Proteins (Proteins, Gene)FDA Link
03/2022 - 01/2010
5Adrenergic beta-Antagonists (beta-Adrenergic Blocking Agents)IBA
01/2020 - 01/2002
4SaltsIBA
01/2022 - 01/2003
4CalciumIBA
10/2021 - 11/2002
4Calcium Channel Blockers (Blockers, Calcium Channel)IBA
09/2021 - 03/2003
4AnticoagulantsIBA
09/2021 - 09/2003
4TroponinIBA
01/2021 - 03/2005
4Glucose (Dextrose)FDA LinkGeneric
09/2020 - 11/2012
4HDL LipoproteinsIBA
11/2016 - 09/2005
4HDL CholesterolIBA
01/2014 - 09/2006
4Digoxin (Digitek)FDA LinkGeneric
05/2010 - 05/2002
3Biomarkers (Surrogate Marker)IBA
01/2023 - 09/2009
3ReninIBA
01/2022 - 11/2012
3Oxidoreductases (Dehydrogenase)IBA
11/2021 - 09/2005
3SodiumIBA
09/2020 - 05/2012
3Warfarin (Coumadin)FDA LinkGeneric
01/2020 - 05/2003
3AnthracyclinesIBA
09/2019 - 05/2018
3Neuroprotective AgentsIBA
07/2018 - 01/2002
3Vasodilator Agents (Vasodilators)IBA
03/2018 - 09/2002
3Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
03/2018 - 07/2008
3ElectrolytesIBA
03/2017 - 09/2006
3Cholesterol Ester Transfer ProteinsIBA
09/2014 - 05/2008
3Anti-Bacterial Agents (Antibiotics)IBA
01/2010 - 07/2002
3Anti-Arrhythmia AgentsIBA
07/2009 - 03/2003
2AutoantibodiesIBA
01/2023 - 03/2012
2LDL Receptors (LDL Receptor)IBA
09/2022 - 05/2010

Therapy/Procedure

66Therapeutics
07/2022 - 03/2002
14Drug Therapy (Chemotherapy)
09/2019 - 03/2002
8Implantable Defibrillators (Implantable Cardioverter-Defibrillator)
11/2020 - 01/2007
8Percutaneous Coronary Intervention
11/2017 - 09/2008
7Length of Stay
07/2016 - 12/2013
5Stents
09/2021 - 05/2004
5Defibrillators (Defibrillator)
12/2010 - 07/2009
4Secondary Prevention
01/2019 - 05/2015
3Patient Readmission
03/2017 - 09/2007